- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 257/00 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 257/00
Total number of patents in this class: 62
10-year publication summary
4
|
5
|
3
|
2
|
3
|
1
|
6
|
1
|
4
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
GE Healthcare AS | 235 |
7 |
The Johns Hopkins University | 5529 |
5 |
Merck Sharp & Dohme LLC | 3746 |
4 |
Boehringer Ingelheim International GmbH | 4751 |
2 |
Fusion Pharmaceuticals Inc. | 82 |
2 |
BWXT ITG Canada, Inc. | 6 |
2 |
F. Hoffmann-La Roche AG | 7938 |
1 |
Merck & Co., Inc. | 447 |
1 |
Merck Sharp & Dohme Corp. | 2219 |
1 |
Honeywell International Inc. | 14012 |
1 |
Allergan, Inc. | 2441 |
1 |
Bayer Cropscience AG | 2141 |
1 |
The United States of America as represented by the Secretary of the Navy | 2722 |
1 |
Commissariat à l'énergie atomique et aux energies alternatives | 10694 |
1 |
The General Hospital Corporation | 4645 |
1 |
Purdue Research Foundation | 3475 |
1 |
ArQule, Inc. | 139 |
1 |
Biophore India Pharmaceuticals Pvt. Ltd. | 71 |
1 |
Bracco Imaging S.p.A. | 315 |
1 |
DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
1 |
Other owners | 26 |